Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Shorter antibiotic course may be just as effective for blood infection

NCT ID NCT05210439

Disease control Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether 7 days of antibiotics works as well as the standard 14 days for treating a serious bloodstream infection caused by Pseudomonas bacteria. About 300 adults who have already received 6 days of treatment will be randomly assigned to stop at 7 days or continue for 14 days. The goal is to see if shorter treatment leads to fewer side effects and less antibiotic use without increasing the risk of death or recurrence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

306 people

The number who actually took part.

Started

Apr 2022

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Main inclusion criteria: * Adult patients with diagnosis of BSI-PA who have received 6 days (+/- 1) of active antibiotic treatment from the date of extraction of the first positive blood culture and until the moment of randomization. * Informed consent signed. Main exclusion criteria: * Bacteremia source not adequately controlled at least 72h before randomization. * Bacteremia secondary to an infection that necessarily requires prolonged antibiotic treatment more than 7 days * Coexistence of a different infection at the time of diagnosis of bacteremia that also requires antibiotic treatment. * Bacteremic pneumonia in severely immunosuppressed patients * Bacteremia of any origin in patients with severe neutropenia (\<500 cells / mm3) at the time of randomization.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bloodstream infection are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

bacterial infectious disease with sepsis Pseudomonas aeruginosa infectious disease Pseudomonas infection Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bloodstream infection

Contacts and locations

Locations

  • Clínica Universidad de Navarra

    Pamplona, Navarre, 31008, Spain

  • Complejo Hospitalario Ciudad de Jaén

    Jaén, 23007, Spain

  • Complejo Hospitalario Torrecárdenas

    Almería, 04009, Spain

  • Complexo Hospitalario Universitario de Vigo

    Vigo, Pontevedra, 36213, Spain

  • Hospital Clínico Universitario de Valladolid

    Valladolid, 47003, Spain

  • Hospital Costa del Sol

    Marbella, Málaga, 29603, Spain

  • Hospital General Universitario Dr. Balmis

    Alicante, 03010, Spain

  • Hospital General Universitario de Valencia

    Valencia, 46014, Spain

  • Hospital San Pedro

    Logroño, La Rioja, 26006, Spain

  • Hospital Universitario Central de Asturias

    Oviedo, Principality of Asturias, 33011, Spain

  • Hospital Universitario Clínico San Cecilio

    Granada, 18016, Spain

  • Hospital Universitario Fundación Jiménez Díaz

    Madrid, 28040, Spain

  • Hospital Universitario Juan Ramón Jiménez

    Huelva, 21005, Spain

  • Hospital Universitario La Fe

    Valencia, 46026, Spain

  • Hospital Universitario La Paz

    Madrid, 28046, Spain

  • Hospital Universitario Lozano Blesa

    Zaragoza, 50009, Spain

  • Hospital Universitario Lucus Augusti

    Lugo, 27003, Spain

  • Hospital Universitario Marqués de Valdecilla

    Santander, 39008, Spain

  • Hospital Universitario Parc Taulí

    Sabadell, Barcelona, 08208, Spain

  • Hospital Universitario Puerta del Mar

    Cadiz, 11009, Spain

  • Hospital Universitario Ramón y Cajal

    Madrid, 28034, Spain

  • Hospital Universitario Regional de Málaga

    Málaga, 29010, Spain

  • Hospital Universitario Reina Sofía

    Córdoba, 14004, Spain

  • Hospital Universitario Son Espases

    Palma de Mallorca, Balearic Islands, 07120, Spain

  • Hospital Universitario Vall d'Hebron

    Barcelona, 08035, Spain

  • Hospital Universitario Virgen Macarena

    Seville, 41009, Spain

  • Hospital Universitario Virgen de Valme

    Seville, 41014, Spain

  • Hospital Universitario Virgen de las Nieves

    Granada, 18014, Spain

  • Hospital Universitario Virgen del Rocío

    Seville, 41013, Spain

  • Hospital Universitario de A Coruña

    A Coruña, 15006, Spain

  • Hospital Universitario de Bellvitge

    L'Hospitalet de Llobregat, Barcelona, 08907, Spain

  • Hospital Universitario de Burgos

    Burgos, 09006, Spain

  • Hospital Universitario de Cruces

    Barakaldo, Bizkaia, 48903, Spain

  • Hospital Universitario de Donostia

    Donostia / San Sebastian, Gipuzkoa, 20014, Spain

  • Hospital Universitario de Jerez de la Frontera

    Jerez de la Frontera, Cádiz, 11407, Spain

  • Hospital Universitario de Puerto Real

    Puerto Real, Cádiz, 11510, Spain

  • Hospital de la Santa Creu i Sant Pau

    Barcelona, 08041, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.